"FMDB_ID","PubMed ID","Reference","Title","Peptide_Sequence","Sequence","Length of peptide","Food_Matrix","Protein","pH","Temperature","Incubation Time","Activity","Experiment","Model","Assay for Activity Measurement","Culture","Hydrolysis","Method of analysis","M_Z ratio","Mass","IC50"
"FMDB1195","25218972","NA","NA","LAFNPTQLEGQCHV","LAFNPTQLEGQCHV","14","Sheep cheese Whey","ovine βlactoglobulin, f(149–162)","NA","45c","4h","Ace-inhibitory","In vitro","NA","Spectrophotometric assay using HHL as substrate","Bacillus sp.P7","protease","nano-ESI-MS","778.8811","NA","NA"
"FMDB1196","25218972","NA","NA","LAFNPTQLEGQCHV","LAFNPTQLEGQCHV","14","Sheep cheese Whey","ovine βlactoglobulin, f(149–162)","NA","45c","4h","Antioxidant","In vitro","NA","ABTS radical scavenging assay","Bacillus sp.P7","protease","nano-ESI-MS","778.8811","NA","NA"
"FMDB1818","15328207","","Structural Analysis of a New Anti-Hypertensive Peptide (β-Lactosin B) Isolated from a Commercial Whey Product","ALPM “β-lactosin B”","ALPM","5","commercial Whey product, WE80BG","β-lactoglobulin","NA","NA","NA","Ace-inhibitory","In vitro","NA","Spectrophometric assay using HHL as substrate","NA","NA","RPHPLC and N terminal sequencing by Edman degradation","NA","NA","928uM"
"FMDB1819","15328207","NA","Structural Analysis of a New Anti-Hypertensive Peptide (β-Lactosin B) Isolated from a Commercial Whey Product","ALPM “β-lactosin B”","ALPM","5","commercial Whey product, WE80BG","β-lactoglobulin","NA","NA","NA","Anti-hypertensive","In vivo","NA","NA","NA","NA","RPHPLC and N terminal sequencing by Edman degradation","NA","NA","928uM"
"FMDB1905","NA","tsai08","Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of Milk","YPYY","YPYY","4","Fermented Milk Whey product (4.5% (w/v) skimmed Milk powder, 5.5% (w/v) whole Milk powder and 7% (w/v) sucrose )","Casein","NA","43c","5h","Ace-inhibitory","In vitro","NA","RP-HPLC modified spectrophotometric assay using HHL as substrate","Streptococcus thermophilus and Lactobacillus bulgaricus + . Flavourzyme from Aspergillus oryzae","protease","RP-HPLC and protein sequencer 492 Procise","NA","NA","90.9uM"
"FMDB1906","NA","tsai08","Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of Milk","YPYY","YPYY","4","Fermented Milk Whey product (4.5% (w/v) skimmed Milk powder, 5.5% (w/v) whole Milk powder and 7% (w/v) sucrose )","Casein","NA","43c","5h","Ace-inhibitory","In vivo","spontaneously Hypertensive Rats","NA","Streptococcus thermophilus and Lactobacillus bulgaricus + . Flavourzyme from Aspergillus oryzae","protease","RP-HPLC and protein sequencer 492 Procise","NA","NA","90.9uM"
"FMDB204","NA","pan10","Optimization of sour Milk fermentation for the production of ACE-inhibitory peptides and purification of a novel peptide from Whey protein hydrolysate","RLSFNP","RLSFNP","6","Whey protein","Bovine Beta lactoglobulin","7.5","39C","20h","Ace-inhibitory","In vitro","NA","Spectrophotometric asay using HHL as substrate","Lb. helveticus LB10","proteinase and peptidase","RPHLC &triple-quadruple mas spectrometer ESI-MS/MS","NA","732.84Da","177.39 μm."
"FMDB2041","NA","ahn09","ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES","AEKTK","AEKTK","5","Reconstituted Whey powder","b-lactoglobulin f73–77","6","37C","36h","Ace-inhibitory","In vitro","NA","Spectrophotometric assay using HHL as substate","Lb. brevisKCTC3102","NA","RP-HPLc and soild phase Edman peptide sequencing","NA","NA","509.1± 0.000ug/ml"
"FMDB2042","NA","ahn09","ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES","AQSAP","AQSAP","5","Reconstituted Whey powder","b-lactoglobulin f34–38","6","37C","36h","Ace-inhibitory","In vitro","NA","Spectrophotometric assay using HHL as substate","Lb. helveticus ATCC 15009","NA","RP-HPLc and soild phase Edman peptide sequencing","NA","NA","238.6 ±49.20ug/ml"
"FMDB2043","NA","ahn09","ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES","IPAVF","IPAVF","5","Reconstituted Whey powder","b-lactoglobulin f78–82","6","37C","36h","Ace-inhibitory","In vitro","NA","Spectrophotometric assay using HHL as substate","Lb. helveticus ATCC 15009","NA","RP-HPLc and soild phase Edman peptide sequencing","NA","NA","5.3 ±0.100ug/ml"
"FMDB2044","NA","ahn09","ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES","APLRV","APLRV","5","Reconstituted Whey powder","b-lactoglobulin f37–41","6","37C","36h","Ace-inhibitory","In vitro","NA","Spectrophotometric assay using HHL as substate","Lb. helveticus ATCC 15009","NA","RP-HPLc and soild phase Edman peptide sequencing","NA","NA","5.3 ±0.100ug/ml"
"FMDB2045","NA","ahn09","ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES FROM WHEY FERMENTED BY LACTOBACILLUS SPECIES","AHKAL","AHKAL","5","Reconstituted Whey powder","α-LA f106–110","6","37C","36h","Ace-inhibitory","In vitro","NA","Spectrophotometric assay using HHL as substate","Lb. helveticus ATCC 15009","NA","RP-HPLc and soild phase Edman peptide sequencing","NA","NA","5.3 ±0.100ug/ml"
"FMDB337","16476172","NA","NA","WLAHK","WLAHK","5","goat Whey","Alpha lactoglobulin","NA","NA","NA","Ace-inhibitory","In vitro","NA","NA","Can parapsilosis and Lb paracasei","protease","NA","NA","NA","NA"
"FMDB37","Ashar MN Chad R","Ashar04","Fermented Milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects","SKVYPFPGPI","SKVYPFPGPI","10","Whey protein","β-Casein","NA","NA","NA","NA","NA","NA","NA","Lactobacillus delbrueckii ssp. bulgaricus","NA","NA","NA","NA","1.7 mg/ml"